LUMINESCENS® is an advanced professional system designed to target common and post-inflammatory hyperpigmentation, melasma, age spots and overall uneven skin tone. Combining in-clinic depigmenting mesotherapy with a dedicated post-treatment home cream, it offers a complete pathway to visibly brighter, more uniform and luminous skin.
Ideal in combination with microneedling and other transdermal delivery technologies, LUMINESCENS® delivers clinically active ingredients into the skin to regulate melanin production, support cellular renewal and protect against oxidative stress over time.
Patients Satisfied
Annual treatment
Tyrosinase Inhibition
Inhibition of melanogenic enzymes – Actives that help inhibit tyrosinase and related proteins to reduce melanin synthesis.
Melanin Modulation
Interference with melanin formation and transport – Copper chelators and MC1R-targeting ingredients help limit the spread and visibility of pigment.
Cellular Renewal
Acceleration of cellular turnover – Keratolytic agents promote exfoliation, helping to lift existing dark spots and smooth skin texture.
Antioxidant Defense
A rich antioxidant complex helps neutralise free radicals and interrupts the oxidative cascade associated with hyperpigmentation.
Advanced Depigmentation & Skin Brightening Therapy
The LUMINESCENS® protocol is built around a synergistic approach:
The in-clinic phase uses 2 × 4 mL vials of depigmenting mesotherapy solution, formulated to be compatible with microneedling and other transdermal delivery devices. Used in structured treatment cycles, the mesotherapy vials are designed to visibly reduce stubborn pigmentation while preparing the skin for the maintenance phase.
Following the professional sessions, LUMINESCENS® Cream is applied at home as an advanced post-treatment cream specifically formulated to extend, stabilise and enhance the results of depigmenting mesotherapy. Used consistently after each treatment cycle, LUMINESCENS® Cream becomes the daily ally for maintaining results, preventing rebound pigmentation and keeping the complexion smooth, even and luminous.
Advanced Depigmentation & Skin Brightening Therapy
The LUMINESCENS® protocol is built around a synergistic approach:
The in-clinic phase uses 2 × 4 mL vials of depigmenting mesotherapy solution, formulated to be compatible with microneedling and other transdermal delivery devices. Used in structured treatment cycles, the mesotherapy vials are designed to visibly reduce stubborn pigmentation while preparing the skin for the maintenance phase.
Following the professional sessions, LUMINESCENS® Cream is applied at home as an advanced post-treatment cream specifically formulated to extend, stabilise and enhance the results of depigmenting mesotherapy. Used consistently after each treatment cycle, LUMINESCENS® Cream becomes the daily ally for maintaining results, preventing rebound pigmentation and keeping the complexion smooth, even and luminous.
+ 1 cream bottle 30 mL
Doctus propriae erroribus an eam, mel agam modus civibus et, vim solet dissentiet cu velit sanctus mei.
Principal Scientist, Translational Biology
Doctus propriae erroribus an eam, mel agam modus civibus et, vim solet dissentiet cu velit sanctus mei.
PRINCIPAL SCIENTIST, TRANSLATIONAL BIOLOGY
Doctus propriae erroribus an eam, mel agam modus civibus et, vim solet dissentiet cu velit sanctus mei.
Principal Scientist, Translational BiologyBenefits at a Glance
LUMINESCENS® is designed for dermatologists, aesthetic doctors and professional skin clinics seeking a complete, protocol-based solution for advanced depigmentation and skin brightening therapy – from in-clinic procedure to home maintenance.
Chemistry testing
Electrical signals
Biological evaluation
Toxicological assessment
Targets hyperpigmentation, melasma, age spots and post-inflammatory hyperpigmentation
Brightens, smooths and refines overall skin tone and texture
Provides hydration, soothing and antioxidant support after procedures
Supports long-term pigment control and skin-quality maintenance
Before & After
The results of LUMINESCENS®
RESULT AFTER: 30 days of treatment
GENDER: Female, AGE: 41
RESULT AFTER: 60 days of treatment
GENDER: Female, AGE: 43
RESULT AFTER: 30 days of treatment
GENDER: Male, AGE: 51


